Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6-Thioguanine in Childhood NHL and ALL Maintenance
NCT02141100Phase 2Withdrawn
- Start
- Jul 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tioguanine in non-Hodgkin lymphoma (NHL), acute lymphoblastic leukemia (ALL). Planned start Jul 2014; status: withdrawn.
02
Drugs
tioguanine
03
Conditions
non-Hodgkin lymphoma (NHL)acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT02141100.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02141100.